MX9803918A - Tabletas de liberacion rapida comprendiendo acido tolfenamico o una sal farmaceuticamente aceptable del mismo como ingrediente activo y un metodo para la preparacion de dicha tableta. - Google Patents

Tabletas de liberacion rapida comprendiendo acido tolfenamico o una sal farmaceuticamente aceptable del mismo como ingrediente activo y un metodo para la preparacion de dicha tableta.

Info

Publication number
MX9803918A
MX9803918A MX9803918A MX9803918A MX9803918A MX 9803918 A MX9803918 A MX 9803918A MX 9803918 A MX9803918 A MX 9803918A MX 9803918 A MX9803918 A MX 9803918A MX 9803918 A MX9803918 A MX 9803918A
Authority
MX
Mexico
Prior art keywords
pharmaceutically acceptable
acceptable salt
rapid release
release tablet
tolfenamic acid
Prior art date
Application number
MX9803918A
Other languages
English (en)
Inventor
Knud Erik Gebhard-Hansen
Karen Bjornsdottir
Lars Hedevang Christensen
Soren Bols Pedersen
Original Assignee
Gea Farmaceutisk Fabrik As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gea Farmaceutisk Fabrik As filed Critical Gea Farmaceutisk Fabrik As
Publication of MX9803918A publication Critical patent/MX9803918A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Una tableta de liberacion rápida comprendiendo un ingrediente activo, seleccionado de ácido tolfenámico y sales farmacéuticamente aceptables. El ingrediente activo tiene un tamaño de partículas <= 10 æm. La tableta comprende ácido algínico o una sal farmacéuticamente aceptable del mismo en una cantidad de 1.5-6.0% por peso y un superdesignante en una cantidad de por lo menos 6.0% por peso.
MX9803918A 1995-12-20 1998-05-18 Tabletas de liberacion rapida comprendiendo acido tolfenamico o una sal farmaceuticamente aceptable del mismo como ingrediente activo y un metodo para la preparacion de dicha tableta. MX9803918A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK144895 1995-12-20

Publications (1)

Publication Number Publication Date
MX9803918A true MX9803918A (es) 1998-09-30

Family

ID=8104933

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9803918A MX9803918A (es) 1995-12-20 1998-05-18 Tabletas de liberacion rapida comprendiendo acido tolfenamico o una sal farmaceuticamente aceptable del mismo como ingrediente activo y un metodo para la preparacion de dicha tableta.

Country Status (27)

Country Link
US (1) US6036975A (es)
EP (1) EP0869783B1 (es)
JP (1) JP2000515489A (es)
CN (1) CN1147295C (es)
AR (1) AR004395A1 (es)
AT (1) ATE234085T1 (es)
AU (1) AU1190097A (es)
BR (1) BR9612057A (es)
CA (1) CA2244396A1 (es)
CZ (1) CZ293422B6 (es)
DE (1) DE69626676T2 (es)
DK (1) DK0869783T3 (es)
EE (1) EE9800186A (es)
ES (1) ES2191781T3 (es)
HR (1) HRP960598A2 (es)
HU (1) HU224030B1 (es)
IL (1) IL124356A (es)
MX (1) MX9803918A (es)
NO (1) NO316869B1 (es)
NZ (1) NZ324674A (es)
PL (1) PL186915B1 (es)
RO (1) RO117589B1 (es)
RU (1) RU2166939C2 (es)
TR (1) TR199801126T2 (es)
TW (1) TW430561B (es)
WO (1) WO1997022340A1 (es)
ZA (1) ZA9610714B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9802973D0 (sv) 1998-09-03 1998-09-03 Astra Ab Immediate release tablet
US6599530B2 (en) * 1998-09-14 2003-07-29 Orion Corporation Oral compacted composition comprising catechol derivatives
IL150053A0 (en) * 1999-12-06 2002-12-01 Mendell Co Inc Edward Pharmaceutical superdisintegrant
CA2311734C (en) * 2000-04-12 2011-03-08 Bristol-Myers Squibb Company Flash-melt oral dosage formulation
WO2005028621A2 (en) * 2003-09-15 2005-03-31 Vitra Bioscience, Inc. Assays with primary cells
WO2007112098A2 (en) * 2006-03-24 2007-10-04 The Texas A & M University System And Safe Et Al Uses of diphenyl/diphenylamine carboxylic acids
TWI405574B (zh) * 2007-06-21 2013-08-21 Otsuka Pharma Co Ltd 藥學固體製劑及其製造方法
US8367427B2 (en) * 2008-08-20 2013-02-05 Baxter International Inc. Methods of processing compositions containing microparticles
WO2018048847A1 (en) * 2016-09-07 2018-03-15 Celgene Corporation Tablet compositions
CN111184707B (zh) * 2020-02-20 2021-04-27 中山大学 托芬那酸或其药学上可接受的盐在制备预防和/或治疗新型冠状病毒炎症药物中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE116061C (es) *
FI89004C (fi) * 1988-02-16 1993-08-10 Pertti J Neuvonen Anvaendning av tillsatsmedel foer oekning av absorptionshastigheten av laekemedel i orala laekemedelspreparat
IT1276689B1 (it) * 1995-06-09 1997-11-03 Applied Pharma Res Forma farmaceutica solida ad uso orale

Also Published As

Publication number Publication date
CN1147295C (zh) 2004-04-28
HRP960598A2 (en) 1998-02-28
DE69626676T2 (de) 2003-12-18
ZA9610714B (en) 1997-06-30
DK0869783T3 (da) 2003-06-02
CA2244396A1 (en) 1997-06-26
CZ194398A3 (cs) 1998-11-11
CN1208345A (zh) 1999-02-17
TW430561B (en) 2001-04-21
AU1190097A (en) 1997-07-14
PL327584A1 (en) 1998-12-21
ATE234085T1 (de) 2003-03-15
NZ324674A (en) 2000-01-28
PL186915B1 (pl) 2004-03-31
NO316869B1 (no) 2004-06-07
HUP9903410A2 (hu) 2000-04-28
WO1997022340A1 (en) 1997-06-26
RO117589B1 (ro) 2002-05-30
RU2166939C2 (ru) 2001-05-20
TR199801126T2 (xx) 1998-08-21
NO982875L (no) 1998-08-19
HUP9903410A3 (en) 2000-05-29
EP0869783B1 (en) 2003-03-12
IL124356A (en) 2001-05-20
DE69626676D1 (de) 2003-04-17
AR004395A1 (es) 1998-11-04
JP2000515489A (ja) 2000-11-21
EE9800186A (et) 1998-12-15
NO982875D0 (no) 1998-06-19
EP0869783A1 (en) 1998-10-14
BR9612057A (pt) 1999-02-23
US6036975A (en) 2000-03-14
CZ293422B6 (cs) 2004-04-14
ES2191781T3 (es) 2003-09-16
HU224030B1 (hu) 2005-05-30
IL124356A0 (en) 1998-12-06

Similar Documents

Publication Publication Date Title
CA2116238A1 (en) Oral 1 .alpha.-hydroxyprevitamin d
IL102591A0 (en) Compositions for the sustained and controlled release of medicaments and their preparation
ATE239454T1 (de) Orale morphinzubereitung in teilchenform
AU3418993A (en) System for delivering an active substance for sustained release
EP0866656A4 (en) INHIBITING THE ALPHA TUMORNESCROSE FACTOR
IL104192A0 (en) Pharmaceutical dosage forms having prolonged release rate of active ingredient
MX9702162A (es) Procedimiento para hacer unidades de dosis mediante granulacion en humedo.
NO944113L (no) Stabilt, hydratisert cefalosporin-tört pulver for oral suspensjonsformulering
DE59908764D1 (de) Agitationsunabhängige pharmazeutische multiple-unit-retardzubereitungen und verfahren zu ihrer herstellung
MX9803918A (es) Tabletas de liberacion rapida comprendiendo acido tolfenamico o una sal farmaceuticamente aceptable del mismo como ingrediente activo y un metodo para la preparacion de dicha tableta.
AU4297089A (en) Dispersable formulation of diclofenac in free acid form
MY124465A (en) Reduction of infarct volume using citicoline
IL126892A0 (en) Pharmaceutical compositions for the sustained release of insoluble active principles
GB9005498D0 (en) Composition
WO2000010525A3 (en) Fish gelatinous composition for use as an ingredient in tablets
HUT63306A (en) Insecticidal compositions comprising guanide derivatives as active ingredient and process for producing the active ingredient
EP0129947A3 (en) Contraceptive compositions based on esters of levo-norgestrel
AU5784096A (en) Method and composition for prevention of posterior capsule opacification
IL116819A (en) Compositions comprising ribozymes targeting the retroviral packaging sequence and an agent which inhibits or prevents hiv-1 replication and use thereof as a medicament for protecting cells from hiv
CA2281474A1 (en) Dosage forms exhibiting multiphasic release kinetics and methods of manufacture thereof
EP0351876A3 (en) Composition for potentiating vaccination effect
EP0987022A4 (en) PREVENTIVE AND HEALING MEDICINES FOR ULCERATIVE KOLITIS AND / OR MORBUS CROHN
CA2099667A1 (en) Agent for treating hepatic diseases
ZA968315B (en) Administration by inhalation of 2-amino-6n-propyl-amino-4,5,,7-tetrahydrobenzothiazole particularly the (-)-enan-tiomer thereof and the pharmacologically acceptable acid addition salts thereof
HUT72427A (en) Herbicide compositions containing glufozinate derivetives and process for producing the active ingredient